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Background: Cervical cancer is necessarily caused by human papillomaviruses, which encode three oncogenes
manifesting their functions by interfering with a number of cellular proteins and pathways: the E5, E6, and E7
proteins. We have earlier found in our microarray studies that the E5 oncogene crucially affects the expression of
cellular genes involved in adhesion and motility of epithelial cells.
Methods: In order to biologically validate our previous experimental findings we performed immunohistochemical
staining of a representative set of tissue samples from different grades of high-risk human papillomavirus associated
cervical disease as well as normal squamous and columnar cervical epithelium. Three-dimensional collagen raft
cultures established from E5-expressing and control epithelial cells were also examined. The expression of p16,
matrix metalloproteinase (MMP) -7, MMP-16, cytokeratin (CK) 8/18, laminin, E-cadherin and beta-catenin was
studied.
Results: In agreement with our previous microarray studies, we found intense staining for E-cadherin and beta-
catenin in adherens junctions even in high-grade cervical lesions. Staining for MMP-16 was increased in severe
disease as well. No significant change in staining for MMP-7 and cytokeratin 8/18 along with the grade of cervical
squamous epithelial disease was observed.
Conclusions: Here we have confirmed, using tissue material from human papillomavirus associated lesions, some
of the cellular gene expression modifications that we earlier reported in an experimental system studying
specifically the E5 oncogene of papillomaviruses. These findings were partially surprising in the context of cervical
carcinogenesis and emphasize that the complexity of carcinogenesis is not yet fully understood. Microarray
approaches provide a wide overwiev of gene expression in experimental settings, which may yield biologically valid
biomarkers for disease diagnostics, prognosis, and follow-up.
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Cervical cancer is necessarily caused by human papillo-
maviruses (HPV) [1]. Cancer-associated high-risk papil-
lomavirus types (hrHPV) confer their oncogenic
functions with the help of viral E5, E6 and E7 onco-
genes. The immortalizing and transforming properties of
the E6 and E7 oncogenes have been well established in* Correspondence: eeva.auvinen@helsinki.fi
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reproduction in any medium, provided the orexperimental systems, and these properties are in agree-
ment with the epidemiological data on the association of
different virus types with human cancer [2]. The func-
tions of the E5 oncogene are not as thoroughly under-
stood, although it is known to stimulate epidermal
growth factor receptor (EGFR) signaling, cell prolifera-
tion and immortalization of keratinocytes [3-7]. In a
transgenic mouse model E5 was recently suggested to
have a crucial role in cervical carcinogenesis [8].
In normal squamous epithelium, E-cadherin–beta-
catenin complexes are important in maintaining the in-
tegrity of adherens junctions between two adjacent cells,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Carcinogenesis is understood to involve breakdown of
adherens junctions, which is seen in reduced expres-
sion or absence of these proteins in intercellular junc-
tions [9]. We have previously explored the effects of
the HPV 16 E5 oncogene on the expression of cellular
genes and microRNAs in two microarray studies using
stable E5-expressing HaCaT keratinocytes and control
cells in order to understand the complexity of the E5
functions [10,11]. Genes involved in cell motility, cell
adhesion and extracellular matrix were overrepresented
among the genes whose expression was significantly
altered due to E5 expression [10,11]. In validation
experiments we showed upregulated expression of E-
cadherin and beta-catenin proteins, important compo-
nents of adherens junctions in epithelial cells, in
monolayer as well as in three-dimensional collagen raft
cultures of E5 expressing cells [11]. The expression of
N-cadherin was also found to be upregulated. In
agreement with these findings, we also observed down-
regulation of miR-324-5p, a cellular microRNA pre-
dicted to target both E-cadherin and N-cadherin
expression [11].
Degradation of the extracellular matrix is an essen-
tial event in carcinogenesis and it requires the activity
of matrix metalloproteinases [12]. Somewhat surpris-
ingly, in our previous microarray experiments we
found that expression of HPV 16 E5 downregulates
the expression of matrix metalloproteinase (MMP) -7,
MMP-12 and MMP-16 mRNA, although protein levels
were similar in E5 expressing and in control cells
[10,11]. Further, enhanced signaling downstream of
fibronectin was suggested by the observed upregulation
and increased activation of paxillin, and increased cell
motility was confirmed in live cell imaging of
wounded monolayer cell cultures [10]. Altogether, the
previously reported effects of the HPV 16 E5 protein
on cellular gene expression seem to favor cell prolif-
eration and tumorigenesis and repress epithelial differ-
entiation, although these findings are not completely
unequivocal [10,11].
The E6 and E7 proteins of hrHPV have a number of
functions associated with key carcinogenic events in
epithelial cells. However, the plethora of activities
ascribed to the E5 protein awaits biological validation.
Here we sought out to study whether the alterations
seen at gene expression level in tissue culture cells
would be manifested in cervical HPV associated disease.
We were also interested in the possibility of finding
feasible biomarkers for the diagnosis, prognosis and
follow-up of cervical disease among the genes and path-
ways affected by the E5 protein. Our results suggest that
experimental approaches to the functions of a single
oncogenic protein may prove biologically relevant in thecontext of a tumor virus, which encodes several pro-
teins interfering with key oncogenic functions. We were
able to confirm several of the original microarray find-
ings, even surprising ones, in human cervical disease,
which is the result of concerted action of viral proteins
in the epithelium. These observations may contribute to
our understanding of HPV pathogenesis and cervical




A total of 50 archival samples fixed in 10 % formaline
and embedded in paraffin were collected from the
archives of the Department of Pathology, Helsinki Uni-
versity Central Hospital. The material comprised sam-
ples from 4 condyloma, 15 cervical intraepithelial
neoplasia grade 1 (CIN1), 27 CIN2, 2 CIN3, and 2
adenocarcinoma in situ (AIS) cases. Four samples from
normal squamous epithelium and two samples from
normal columnar epithelium with endocervical glands
were studied as well. The use of archival samples was
approved by the Coordinating Ethical Committee of the
Helsinki University Central Hospital.
Preparation of collagen raft cultures
Collagen raft cultures were prepared using a HaCaT cell
line with stable HPV 16 E5 gene expression (HaCaT-E5)
and a control HaCaT cell line without the E5 gene
(HaCaT-pMSG) [13] to produce a three-dimensional tis-
sue culture mimicking differentiating layered epithelium
[14]. Similar cultures were produced using human kera-
tinocytes expressing HPV16 E6 or E7 protein. After
21 days of culture, the epithelial cell rafts were first
fixed overnight in 0.1 % glutaraldehyde/1 % formalde-
hyde/2 % Bacto agar containing salts and buffer, further
fixed overnight in 10 % formaline, and embedded in
paraffin.
Immunohistochemical staining
For immunohistochemical staining, 4–5 μm sections
were prepared and immunostainings were performed
using the automatic Ventana Discovery tissue staining
instrument (Ventana Medical Systems, Tucson, AZ).
Antibodies for the individual cellular proteins are
described in Table 1. Ventana DAB Map kit was used
for detection, and the sections were counterstained with
hematoxylin and postcounterstained with Bluing Re-
agent (Ventana Medical Systems). Finally, the slides were
rinsed and dehydrated before mounting with EuKitt
Mounting Medium (Fluka, Sigma-Aldrich Inc., Saint
Louis, MO). Thickness and intensity of each staining
were evaluated and given a value 0–3. The average
staining thickness and intensity rankings for each
Table 1 Primary antibodies used in tissue staining experiments
Antibody Identification Dilution Source
p16INK4a E6H4 undiluted mtm laboratories AG, Heidelberg, Germany
MMP-7 Clone ID2 1:30 Calbiochem, Merck Chemicals Ltd., Nottingham, UK
MMP-12 rabbit polyclonal 1:50 Sigma-Aldrich Inc., Saint Louis, MO
MMP-16 rabbit polyclonal 1:50 Sigma-Aldrich Inc., Saint Louis, MO
CK8/18 Clone 5D3 1:50 Novocastra Lab’s Ltd., Vision Biosystems, Newcastle, UK
Laminin rabbit polyclonal 1:350 DakoCytomation, Glostrup, Denmark
EDA-Fibronectin Clone 52DH1 1:30 Dr Ismo Virtanen [15]
E-cadherin Clone 36 1:200 BD Transduction Laboratories, Franklin Lakes, NJ
N-cadherin Clone GC-4 1:30 Sigma-Aldrich Inc., Saint Louis, MO
Beta-catenin Clone 14 1:30 BD Transduction Laboratories, Franklin Lakes, NJ
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Results
In our previous work we showed that expression of the
E5 oncogene of HPV type 16 leads to increased expres-
sion of E-cadherin and beta-catenin proteins in mono-
layer cell cultures and in three-dimensional collagen raft
cultures [11]. We continued to perform immunohisto-
chemical staining for these proteins in human cervical
hrHPV-associated disease. Our material covered condyl-
oma, CIN1-3 and AIS, as well as normal squamous and
columnar epithelium. In each type of HPV associated
disease, thickness and intensity of staining were separ-
ately graded 0–3. The averages for normal tissue and
disease tissue are shown in Table 2.
In order to visualize the dysplastic area of cervical tis-
sue, antibody to p16 (p16INK4a) was used as a surrogate
marker for the presence of hrHPV. p16 is not expressed
in normal squamous epithelium (Figure 1.1), condyloma
tissue (Figure 1.2), or normal columnar epithelium (Fig-
ure 1.6). In hrHPV-associated dysplastic lesions (CIN1-
3), cytoplasmic as well as nuclear staining for p16INK
was seen, correlating with the severity of the lesionTable 2 Average of thickness and intensity of immunohistoch
in each morphological class
p16 MMP-7 MMP-16 CK
th int th int th int th
Normal SE 0 0 1 1 1-2 1 0
Condyloma 0 0 1–2 1–2 2 1 0–
CIN1 1–2 1–2 1–2 1–2 2–3 1–2 0–
CIN2 1–2 2 1–2 1–2 2–3 1–2 0–
CIN3 1–2 3 1–2 1–2 2–3 2–3 1
Normal CE n.a. 0 n.a. 1 n.a. 1 n.a
AIS 3 3 0–1 1 1–2 1–2 0–
Thickness (th) and intensity (int) of staining are evaluated in a scale from 0 (no stain
normal squamous epithelium. Normal CE, normal columnar epithelium. b-catenin =
epithelium.(Figure 1.3-5; Table 2). In CIN1, the lower part of the
dysplastic epithelium was positive for p16INK, whereas
the superficial koilocytotic areas remained negative.
More intense staining covering an increasing proportion
of the epithelial thickness was seen in CIN2 and CIN3.
In AIS, staining for p16INK was strongly positive and
shows clearly the dysplastic area of cervical epithelium
(Figure 1.7). HPV associated neoplasia and carcinoma
could thus be visualized by using p16 staining.
Cervical tissue was stained for MMP-7 and MMP-16
(Figure 1.8-14, 1.15-21). Some background signal
remained in MMP-16 staining despite modifications of
the protocol. Both MMP-7 (Figure 1.8-9) and MMP-16
(Figure 1.15-16) are expressed in the nuclei of basal and
suprabasal cells of normal squamous epithelium and
condyloma. Mitotic figures are nicely stained, as well as
inflammatory cells in the stroma. The expression of
MMP-16 increases along with disease stage, and there is
a strong tendency towards additional cytoplasmic stain-
ing for MMP-16 in the dysplastic area. The expression
of MMP-7 remains altogether fairly similar in various
disease stages (Figure 1.8-14; Table 2). Columnar cell
nuclei and AIS were stained for MMP-7 and MMP16 as
well, and a strong additional cytoplasmic staining wasemical staining signal for the different cellular proteins
8/18 Laminin E-cadherin b-catenin
int th int th int th int
0 0 0 1-2 2 1-2 2
1 2 0 0 2–3 2–3 2–3 2
1 1–2 0–1 1 2–3 2–3 2–3 2–3
1 1–2 0–1 1 2–3 2–3 2–3 2–3
1 1–2 1 3 3 2–3 2–3
. 1-2 n.a. 0 n.a. 1 n.a. 1
1 1 0–1 1 3 3 2 2–3
ing) to 3 (full thickness of epithelium or very intense staining). Normal SE,
beta-catenin. n.a., not applicable due to single layer nature of normal columnar
Figure 1 Immunohistochemical staining for cellular proteins p16 (fields 1–7), MMP-7 (8–14), MMP-16 (15–21), cytokeratin 8/18 (CK8/
18) (fields 22–28), laminin (29–35), E-cadherin (36–42) and beta-catenin (43–49) in different grades of high-risk HPV associated cervical
disease. SE, squamous epithelium; CE, columnar epithelium; AIS, adenocarcinoma in situ. Original magnification 20x.
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ments intense nuclear staining for MMP-12 was
observed, but no grading along with disease status was
seen (not shown). We previously found decreased MMP
mRNA expression due to E5, however, the proteins
levels remained unchanged [10].
The simple epithelial cytokeratin (CK) 8/18 showed no
expression or very weak expression in basal/suprabasal
cell cytoplasms along the basal lamina in normal squa-
mous epithelium, condyloma or CIN1-2 (Figure 1.22-
25). In CIN3, instead, individual cell cytoplasms were
positive for CK 8/18 (Figure 1.26). These cells were scat-
tered in all layers of the dysplastic tissue from basal cells
up to the epithelial surface. The simple epithelial nature
of CK 8/18 was emphasized by the strong basolateral
staining in normal columnar epithelium (Figure 1.27).
Intense cytoplasmic staining was observed in AIS
(Figure 1.28).
Laminin staining was altogether relatively weak. A
faint laminin staining was seen at the basement mem-
brane of normal squamous epithelium and condyloma(Figure 1.29-30). In CIN1 a cytoplasmic staining starting
from basal cells and reaching approximately one-third or
one-half of the epithelium was observed (Figure 1.31). In
CIN 2–3 a stronger staining in basal lamina but no cyto-
plasmic staining was seen (Figure 1.32-33). Some stro-
mal staining was seen as well. Normal columnar
epithelium was not stained for laminin, and in AIS occa-
sional weak staining at the basolateral surface or in cell
cytoplasms was observed (Figure 1.34-35). The laminin
antibody recognizes laminins expressed at the basal lam-
ina, but more accurate information about its exact re-
activity to different laminin chains is not available. We
also stained a subset of samples for fibronectin involved
in cell adhesion, but the signal remained very weak
altogether (not shown). The fibronectin antibody recog-
nizes the extra domain A form of fibronectin [15].
Increased staining along with disease stage was found
for the adherens junction proteins E-cadherin and beta-
catenin. In normal squamous epithelium and condyloma
membrane staining at adherens junctions covered ap-
proximately one-half of the epithelium (Figure 1.36-37,
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lium cytoplasmic staining was observed as well. In
CIN1, intense membrane staining covered two-thirds of
the epithelial thickness, and in the differentiated cells of
the surface the staining was weak or absent (Figure 1.38,
1.45). In CIN2, strong membrane staining covered the
whole epithelium and occasionally a more intense zone
was observed in the middle layers of the epithelium (Fig-
ure 1.39, 1.46). In CIN3, very strong membrane staining
was seen throughout the dysplastic epithelium (Fig-
ure 1.40, 1.47). In CIN2-3 also cytoplasmic staining was
seen in the dysplastic area. Faint basolateral staining for
E-cadherin and beta-catenin was seen in normal colum-
nar epithelium (Figure 1.41, 1.48). Strong membrane
staining together with weak cytoplasmic reactivity for
both proteins was observed in AIS (Figure 1.42, 1.49). In
a subset of tissue samples stained for N-cadherin, a simi-
lar trend towards more intense staining along with the
grade of lesion was seen (not shown).
Interestingly, in our previous work, stronger mem-
brane staining for E-cadherin and beta-catenin was seen
in E5 expressing three-dimensional epithelial raft cul-
tures than in cells devoid of E5 [11]. Moreover, in that
work, strongest staining was seen at and close to the
surface of the epithelial structure, opposite to human
cervical tissue. Figure 2 presents an example of E-
cadherin and beta-catenin staining in raft cultures from
HaCaT-E5 cells expressing HPV 16 E5 protein and
HaCaT-pMSG control cells without HPV. Membrane
staining for E-cadherin and beta-catenin was stronger in
E5-expressing cells than in control cells. Both E5 and
control raft cultures remained completely negative for
p16, MMP-7, MMP-16, and CK8/18 (not shown). Raft
cultures were not stained for laminin.Figure 2 Example of immunohistochemical staining in collagen
raft cultures. Staining for E-cadherin and beta-catenin in raft
cultures established from human keratinocytes expressing HPV 16 E5
protein (HaCaT-E5) or control cells (HaCaT-pMSG). In each field the
surface of the epithelial equivalent is facing upwards. Original
magnification 20x.Altogether our results show the potential of experi-
mental tissue culture settings to display the pathogenic
events in human disease.
Discussion
Here we have studied the expression of selected proteins
implicated in cell adhesion, motility, and differentiation
in cervical dysplasia associated with high-risk human
papillomavirus infection. We have previously reported
large-scale gene and microRNA profiling in epithelial
cells expressing the HPV 16 E5 oncogene [10,11]. In
those studies the E5 protein was found to affect crucial
cellular pathways including cell adhesion, cell motility,
extracellular matrix and mitogenic signaling, and those
effects were partially shown to be mediated by micro-
RNA regulation [10,11].
In the present work we sought out to study whether
altered cellular gene expression profiles found in an ex-
perimental setting would apply to human cervical dis-
ease. We studied altogether 50 samples representing
human cervical disease of different grades, together with
four samples representing normal squamous epithelium
and two from columnar cervical epithelium. The aim of
the study was to perform preliminary biological valid-
ation of gene expression microarray findings in human
disease, and to search for putative feasible biomarkers
for disease diagnostics. The study was limited by the
availability of reliable antibodies to cellular proteins for
immunohistochemical staining. Further, the sample
number per histological grade is rather small and thus
our results are rather of suggestive nature. However, we
were able, by using tissue samples from human cervical
disease, to validate trends of altered expression of several
genes which were first identified in microarray.
Matrix metalloproteinases are proteins that degrade
the extracellular matrix and are thus essential in a num-
ber of physiological processes and pathological condi-
tions including embryonic development, differentiation,
tissue remodeling and cancer [12], also in cervical cancer
[16]. Specifically the involvement of MMP-2, MMP-9
and MMP-14 in cervical carcinogenesis has been
reported [17-19]. Expression of MMP-7 has been found
to correlate with invasive property and advanced tumor
stage of head and neck squamous cell carcinoma [20],
and endometrial [21] and gastric adenocarcinoma [22].
This seems to be tumor type specific, however, since
most cervical neoplasia and carcinoma cases were found
negative for MMP-7 [17]. Interestingly, in a previous
study no expression of MMP-12 or MMP-16 was found
in HPV harboring cervical carcinoma cell lines [23].
In the present study we found increasing staining for
MMP-16 along with the development of cervical dyspla-
sia, in agreement with a number of previous studies,
whereas MMP-7 expression remained virtually similar.
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carcinogenic process is not fully understood, this seems
to disagree with our previous finding of reduced MMP-7
and MMP-16 mRNA expression in monolayer cells
expressing the E5 protein [10], albeit protein expression
in that study remained unchanged, similar to what we
have shown here for MMP-7 in tissue samples. That re-
sult may have been due to increased half-life of the tran-
scripts or increased degradation of the protein.
Altogether, effects of the E5 oncogene as seen in micro-
array may only represent early and/or partial conse-
quences of human papillomavirus in infected epithelial
cells. In this work, both MMP-7 and MMP-16 were
found to be expressed in the nuclei of basal and supra-
basal cells of normal squamous epithelium and condyl-
oma. Most reports describe MMP localization at the
level of tissue, not within cells, and only a few papers
discuss the function of nuclear MMP localization. How-
ever, nuclear localization of proteolytically active MMP-
2 in cardiac myocytes, and MMP-3 in cultured cells and
in human liver tissue has been shown [24,25]. MMP-2
cleaves PARP in the nucleus of cardiac myocytes, and
the authors speculate that this might inhibit DNA dam-
age repair by PARP [24]. The effects of PARP inhibition
in cancer, however, have been shown to be contradictory
[26]. Nuclear MMP-3 seems to be involved in the induc-
tion of apoptosis [25]. Although our findings do not
allow further speculation due to modest changes in
MMP expression, the putative functions of nuclear
MMP’s are worth further studies considering the process
of cervical carcinogenesis.
Keratin-8 is often paired with keratin-18 and is
expressed in simple epithelia [27]. Here we show rea-
sonably strong scattered expression of cytokeratin-8/18
in severe intraepithelial neoplasia. The expression of
CK8/18 in squamous epithelium is an unresolved issue,
although its expression has been previously shown in
high-grade CIN and squamous cell cervical cancer [27-
29]. Poor prognosis has been correlated with cytokera-
tin 8/18 expression in squamous cell carcinoma of the
oral cavity [30]. CK8/18 expression was shown in car-
cinoma induced by inoculating nude mice with tumori-
genic HPV 16-immortalized keratinocytes [31]. Our
results agree with the previous data, because normal
squamous epithelium, low-grade lesions, and even
CIN2 were basically negative for CK8/18, whereas
strong although scattered expression was shown in
CIN3.
Laminin-5 enhances cellular migration and tumorigen-
icity, and it has been shown to be overexpressed in cer-
vical cancer [32]. High-risk HPV E6 oncogene has been
previously shown to upregulate laminin-5 receptor ex-
pression in cervical cancer cells [33]. This takes place by
E6-mediated downregulation of human miR-218, leadingto upregulation of its target gene LAMB3, which is a
component of the laminin-5 receptor expressed in the
basal lamina [33]. On the contrary, in our study the
staining for laminin was strongest in CIN1, whereas in
other tissues laminin was seen only in the basal lamina.
Unfortunately exact information about the reactivity of
the antibody was unavailable and thus we cannot further
speculate about the role of laminin in CIN1. This is,
however, an extremely interesting finding, considering
the possible early events towards carcinogenesis being
evident already in a low-grade lesion.
Carcinogenesis essentially involves downregulation of
E-cadherin and disruption of E-cadherin–beta-catenin
complexes in adherens junctions [9]. Along with the
malignant development, the E-cadherin–beta-catenin
complex at the plasma membrane is degraded and beta-
catenin is transported to the nucleus where it acts as a
transcription factor in the Wnt signaling pathway and
contributes to malignant development. Differences in
intercellular junctions even among morphologically
similar cells may be a manifestation of a crucial event
in cervical carcinogenesis [34,35]. The expression of E-
cadherin and beta-catenin in HPV-associated cervical
neoplasia is, however, equivocal. Decreased and cyto-
plasmic expression of those proteins in cervical cancer
has been reported [36-39]. Leong et al. showed weaken-
ing and dysregulated E-cadherin expression in HPV
harboring lesions [40]. Those authors showed that al-
though downregulation of E-cadherin has previously
been associated with the development of neoplasia and
cancer, it seems to have little to do with the carcino-
genic process and seems to be unrelated to the ability
of the E6 and E7 proteins to bind and degrade pRb or
p53 [40]. Quite the opposite, in the present work we
found increased membrane and cytoplasmic staining for
both E-cadherin and beta-catenin in high-grade cervical
lesions. In agreement with this, Samir et al. reported
increased E-cadherin expression with increasing CIN
grade [41].
We have previously shown increased expression of E-
cadherin and beta-catenin due to E5 expression in epi-
thelial cells [11]. We further observed downregulation of
cellular miR-324-5p, which we showed to putatively tar-
get both E-cadherin and beta-catenin, and thus its
downregulation would lead to increased expression of
the target proteins [11]. In the present work, in agree-
ment with previous observations, we observed increased
expression of E-cadherin and beta-catenin due to E5, E6
and E7 oncogenes in three-dimensional collagen raft cul-
tures. This is in agreement with the increased expression
found in high-grade human cervical tissue. Interestingly,
most intense staining in E5-expressing raft cultures was
seen in the most differentiated layers of the raft epithe-
lium, contrary to normal tissue, condyloma or CIN1,
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layers of the epithelium. In raft cultures expressing the
E6 and E7 oncogenes the strongest staining was seen in
the lower part of the raft epithelium, similar to human
tissue. This repeated observation might be explained by
decreased expression of adhesion molecules towards
fully differentiated and desquamating cells which are
found in normally maturing but not in neoplastic
epithelium.
Extracellular matrix-degrading proteins may be
involved in modification of intercellular junctions. It
has been speculated that MMP-7 expressed on the sur-
face of carcinoma cells may cleave E-cadherin and fa-
cilitate the detachment of carcinoma cells from the site
of primary tumor [42], although we did not see this in-
verse relationship of expression in our work. The ex-
pression of the secreted extracellular matrix-degrading
proteinase MMP-7 has been shown to be upregulated
by beta-catenin in colon tumor cell lines, and a crucial
role prior to the onset of the invasive phenotype has
been suggested [43]. We observed increased membrane
and cytoplasmic staining for beta-catenin along with
the severity of the lesions, including AIS, whereas
MMP-7 expression remained virtually similar. Regula-
tion of various cellular functions participating in car-
cinogenesis is complex. For example, the role of
integration of the HPV genome into the chromosome
in the differential expression of cellular proteins is
poorly understood.
For normal epithelial development, basal epithelial
cells have to detach from integrin and laminins of the
basement membrane, cease to proliferate, and enter the
differentiation program. In epithelial dysplasia or cancer,
cells do not differentiate but continue to proliferate.
Many of the phenomena seen in cervical intraepithelial
neoplasia and cancer are the results of viral oncoprotein
functions. A number of observations based on cervical
morphology and tissue staining have led to better under-
standing of cervical pathogenesis. Also, careful examin-
ation of viral functions in experimental systems
contribute to our knowledge of carcinogenesis and, im-
portantly, may provide novel biomarkers for the diagno-
sis, follow-up and cure of cervical disease.
Conclusion
In conclusion, our results suggest that experimental
approaches such as tissue culture and microarray can
provide valuable preliminary insight into the pathogen-
esis of human disease. Papillomavirus biology and the
effects of HPV in infected cells are not fully understood.
Importantly, optimally prognostic biomarkers would be
of great impact in the management of HPV associated
disease, where only a minor but clinically important sub-
set finally develops into severe lesions and cancer.Abbreviations
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